A Novel Immunodominant CD8+ T Cell Response Restricted by a Common HLA-C Allele Targets a Conserved Region of Gag HIV-1 Clade CRF01_AE Infected Thais
Year: 2011
Type: article
Study design: Observational Study
Abstract: BACKGROUND: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversity of HIV-1 represents a critical hurdle to developing an effective HIV-1 vaccine, and it is likely that regional-specific vaccine strains will be required to overcome the diversity of the different HIV-1 clades distributed world-wide. Unfortunately, little is known about the CD8+ T cell responses against CRF01_AE, which is responsible for the majority of infections in Southeast Asia. METHODOLOGY/PRINCIPAL FINDINGS: To identify dominant CD8+ T cell responses recognized in HIV-1 clade CRF01_AE infected subjects we drew upon data from an immunological screen of 100 HIV-1 clade CRF01_AE infected subjects using IFN-gamma ELISpot to characterize a novel immunodominant CD8+ T cell response in HIV-1 Gag restricted by HLA-Cw*0102 (p24, (277)YSPVSILDI(285), YI9). Over 75% of Cw*0102+ve subjects targeted this epitope, representing the strongest response in more than a third of these individuals. This novel CD8 epitope was located in a highly conserved region of HIV-1 Gag known to contain immunodominant CD8 epitopes, which are restricted by HLA-B*57 and -B*27 in clade B infection. Nonetheless, viral escape in this epitope was frequently observed in Cw*0102+ve subjects, suggestive of strong selection pressure being exerted by this common CD8+ T cell response. CONCLUSIONS/SIGNIFICANCE: As HLA-Cw*0102 is frequently expressed in the Thai population (allelic frequency of 16.8%), this immunodominant Cw*0102-restricted Gag epitope may represent an attractive candidate for vaccines specific to CRF01_AE and may help facilitate further studies of immunopathogenesis in this understudied HIV-1 clade.
Source: PLoS ONE
Authors: Supranee Buranapraditkun, Ursula Hempel, Patrawadee Pitakpolrat, Rachel L. Allgaier, Pattarawat Thantivorasit, Sven-Iver Lorenzen, Sunee Sirivichayakul, William H. Hildebrand, Marcus Altfeld, Christian Brander, Bruce D. Walker, Praphan Phanuphak, Pokrath Hansasuta, Sarah L. Rowland-Jones, Todd M. Allen, Kiat Ruxrungtham
Institutions: Chulalongkorn University, Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology, University of Oklahoma Health Sciences Center, University of Oklahoma, Institució Catalana de Recerca i Estudis Avançats, IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Thai Red Cross Society, John Radcliffe Hospital, MRC Human Immunology Unit, Medical Research Council
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,382
Funders: Higher Education Research Promotion, National Center for Genetic Engineering and Biotechnology, Royal Golden Jubilee (RGJ) Ph.D. Programme, National Institutes of Health, U.S. Public Health Service, Office of the Higher Education Commission, National Institute of Allergy and Infectious Diseases, Division of Chemistry
OpenAlex ID: W1971387155
